Mayo Clinic Forms Joint Venture with Cancer Genetics

Mayo Clinic and Cancer Genetics Inc. (OTCQB: CGIX) launched OncoSpire Genomics, a joint venture with the singular goal of improving cancer care by discovering and commercializing diagnostic tests that leverage next-generation sequencing.

Source: Mayo Clinic Business News - May 23, 2013 Category: Pharmaceuticals Authors: Mayo Clinic Source Type: news